Ignite Creation Date:
2024-05-06 @ 7:17 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05955508
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2023-07-13
Brief Title:
A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2032-12-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-12-19
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-13
First Submit QC Date:
July 13 2023
Study First Post Date:
2023-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-06-10
Last Update Post Date Type:
ACTUAL